Actionable insights straight to your inbox


IPO Report: Flexion Therapeutics (FLXN)

Flexion Therapeutics (FLXN) is a specialty pharmaceutical company focused on the development and commercialization of novel, long-acting, injectable pain therapies. FLXN is In Phase 2
The full IPO calendar is available at Ranked by size of IPO, largest first. (1)  Based in Troy, MI, Talmer Bancorp (TLMR) scheduled a $210 million IPO on the Nasdaq with a